Skip to main content
Caplight Logo









Effectivate

Effectivate

Private
Tel AvivHealthcare & Life Scienceshttps://effectivate.com/

Last Round

Accelerator

Apr 2, 2023

Company Overview

Effectivate operates in Healthcare & Life Sciences and is based in Tel Aviv. Its latest recorded funding round was an Accelerator round in April 2023.

Effectivate is a healthtech company that provides an AI-powered, science-based brain training platform designed to improve memory and cognitive function in older adults.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Patient Engagement

Business Model

B2C

Customer Profile

Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Effectivate Comparables

Compare Effectivate with similar companies based on industry and business-model similarity.

Effectivate comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CogniFit
84%
Posit Science Corporation
84%
Lumosity
82%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Effectivate Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorApr 2, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Shai Granot

CEO & Co-Founder

Founding Team

For institutional investors. Book with your work email.

Effectivate Investors

Notable investors and investment history

Effectivate investors
InvestorRounds
MassChallenge IsraelAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors grew 413% MoM, from 1.6K to 8.3K.

  • Apr 11, 2025

    Grew 18% QoQ from 33 to 39 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Effectivate Filings

Explore SEC and related filing metadata, where available.

Effectivate filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Effectivate's valuation, stock price, and market status.

Is Effectivate a public or private company?

Effectivate is a private company.

What is the current stock price of Effectivate?

Effectivate is a private company, so its shares have no public market price. Caplight tracks Effectivate's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Effectivate worth (valuation)?

Valuation information for Effectivate is not publicly available.

Can I buy Effectivate stock?

Effectivate shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Effectivate's last funding round?

Effectivate's most recent funding round was Accelerator on April 2, 2023.

Who are the main investors in Effectivate?

Key investors in Effectivate include MassChallenge Israel.

Will Effectivate IPO soon?

No public IPO plans have been announced for Effectivate.

How can I track Effectivate secondary market activity?

Caplight tracks bids, offers, and trades in Effectivate's shares on secondary markets.

Firmographic Details

HeadquartersTel Aviv
Employee Range31
Year Founded2018
Last FundingApr 2, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?